Xtant Medical Holdings, Inc. acquired NanOss Production Operations of RTI Surgical, Inc. for $2.2 million.
October 22, 2023
Share
Xtant Medical Holdings, Inc. (NYSEAM:XTNT) acquired NanOss Production Operations of RTI Surgical, Inc. for $2.2 million on October 23, 2023. Under the terms of the purchase agreement, Xtant acquired certain assets, including equipment and inventory, used in RTI?s synthetic bone graft business, and assumed from RTI the lease for the nanOss production facility located in Greenville, NC. The purchase price for the assets was $2 million in cash plus $0.2 million of contingent payments based on future sales of next generation nanOss products.
Xtant Medical Holdings, Inc. (NYSEAM:XTNT) completed the acquisition of NanOss Production Operations of RTI Surgical, Inc. on October 23, 2023. Dennis F. Adams III, Helyn S. Goldstein, Jeffrey D. Osterman, Michael Nissan, Ryan C. Taylor, Vynessa Nemunaitis and Yehudah L. Buchweitz of Weil, Gotshal & Manges LLP acted as legal advisor to Surgalign Holdings, Inc.
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.